Skip Navigation

Edina Avdic, Pharm.D., M.B.A., BCPS AQ-ID

Edina Avdic, Pharm.D., M.B.A., BCPS AQ-ID

Associate Director, Adult Antimicrobial Stewardship Program
Program Director, Infectious Diseases Pharmacy Specialty Residency

Education and Training
Professional Memberships
Clinical and Research Interests
Selected Publications
Contact Information

Education and Training

Pharm.D., Drake University, College of Pharmacy and Health Sciences, Des Moines, IA. (2003)
M.B.A., Drake University, College of College of Business and Administration, Des Moines, IA. (2003)
Pharmacy Practice Residency, Hospital of the University of Pennsylvania, Philadelphia, PA (2004)
Infectious Diseases Pharmacy Residency, Hospital of the University of Pennsylvania, Philadelphia, PA (2005)

Professional Memberships

American Society of Health-System Pharmacists
Maryland Society of Health-System Pharmacists
Society of Infectious Disease Pharmacists
Society for Healthcare Epidemiology of America

Clinical and Research Interests

Dr. Avdic’s practice and research interests are in the area of antimicrobial stewardship and management of patients with multidrug-resistant organisms. She is committed to the development of tools and methods that promote optimal antimicrobial use, use of rapid diagnostic assays as a tool to optimize antimicrobial therapy and education of healthcare professionals on the subject of appropriate antimicrobial use and development of resistance.

Selected Publications

  1. Banoub M, Curless MS, Smith JM, Jarrell AS, Cosgrove SE, Rock C, Avdic E. Higher versus Lower Dose of Cefotetan or Cefoxitin for Surgical Prophylaxis in Patients Weighing One Hundred Twenty Kilograms or More. Surg Infect (Larchmt) 2018;19(5):504-509.
  2. Smith TT, Tamma PD, Do TB, Dzintars KE, Zhao Y, Cosgrove SE, Avdic E. Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium. Diagn Microbiol Infect Dis 2018; 91(2):161-163.
  3. Avdic E, Wang R, Li DX, Tamma PD, Shulder SE, Carroll KC, Cosgrove SE. Sustained impact of a rapid microarray-based assay with antimicrobial stewardship interventions on optimizing therapy in patients with Gram-positive bacteraemia. J Antimicrob Chemother 2017; 72 (11): 3191-8.
  4. Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Adverse Events Associated with Antibiotic Use in Hospitalized Patients. JAMA Intern Med 2017;177 (9):1308-15.
  5. Tamma PD, Avdic E, Keenan JF, Zhao Y, Anand A, Cooper J, Dezube R, Hsu S, Cosgrove SE. What is the More Effective Antibiotic Stewardship Intervention: Pre-Prescription Authorization or Post-Prescription Review with Feedback? Clin Infect Dis. 2017; 64(5):537-543.
  6. Li DX, Ferrada MA, Avdic E, Tamma PD, Cosgrove SE. Sustained Impact of an Antibiotic Stewardship Intervention for Community-Acquired Pneumonia. Infect Control Hosp Epidemiol 2016; 37(10):1243-6.
  7. Wang R, Cosgrove SE, Tschudin-Sutter S, Han JH , Turnbull AE ,  Hsu AJ , Avdic E, Carroll KC, Tamma PD. Cefepime Therapy for cefepime-susceptible extended-spectrum beta-lactamase–producing enterobacteriaceae bacteremia. Open Forum Infect Dis 2016;3(3):ofw132. doi: 10.1093/ofid/ofw132.
  8. Hsu AJ, Carroll KC, Milstone AM, Avdic E, Cosgrove SE, Vilasoa M, Tamma PD. The use of a combination antibiogram to assist with the selection of appropriate antimicrobial therapy for carbapenemase-producing Enterobacteriaceae infections. Infect Control Hosp Epidemiol. 2015; 27:1-3.
  9. Smith JM, Avdic E, Tamma PD, Zhang L, Carroll KC, Cosgrove SE. Risk factors for resistance to beta-lactam/beta-lactamase inhibitors and ertapenem in Bacteroides species bacteremia. Antimicrob Agents Chemother. 2015; 59 (8):5049-51.
  10. Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, Avdic E, Cosgrove SE; for the Antibacterial Resistance Leadership Group. Carbapenem therapy is associated with improved survival compared to piperacillin-tazobactam for patients with ESBL bacteremia. Clin Infect Dis. 2015; 60(9):1319-25.
  11. Buckel WR, Avdic E, Carroll KC, Gunaseelan V, Hadhazy E; Cosgrove SE. Gut check: Clostridium difficile testing and treatment in the molecular testing era. Infect Control Hosp Epidemiol. 2015; 36(2):217-21.
  12. Avdic E, Cushinotto LA, Hughes AH, Hansen AR, Efird LE, Bartlett JG, Cosgrove SE. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis 2012; 54(11):1581-7.

Contact Information

600 North Wolfe Street, Halsted 835
Baltimore, MD 21287

Phone: 443-287-4570

back to top button